A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Clinical trial NCT05419635 · COMPLETED

Trial details

NCT number: NCT05419635
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Thromboembolic Events Atrial Fibrillation Acute Myocardial Infarction Non-cardioembolic Ischemic Stroke Hepatic Impairment

Start date: 2022-06-14
Primary completion: 2023-05-24
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.